Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challenge

Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients

(2011) Heloisa Sawaya et al.   AMERICAN JOURNAL OF CARDIOLOGY

The Utility of Cardiac Biomarkers, Tissue Velocity and Strain Imaging, and Cardiac Magnetic Resonance Imaging in Predicting Early Left Ventricular Dysfunction in Patients With Human Epidermal Growth Factor Receptor II–Positive Breast Cancer Treated With Adjuvant Trastuzumab Therapy

(2011) Nazanin Fallah-Rad et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiovascular complications of conventional and targeted adjuvant breast cancer therapy

(2010) N. Harbeck et al.   ANNALS OF ONCOLOGY

Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours

(2010) T Gelardi et al.   BRITISH JOURNAL OF CANCER

The Vulnerability of the Heart As a Pluricellular Paracrine Organ

(2010) Gilles W. De Keulenaer et al.   CIRCULATION RESEARCH

Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology

(2010) Thomas Eschenhagen et al.   EUROPEAN JOURNAL OF HEART FAILURE

Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study

(2010) E. Ho et al.   HEART

Longer-Term Assessment of Trastuzumab-Related Cardiac Adverse Events in the Herceptin Adjuvant (HERA) Trial

(2010) Marion Procter et al.   JOURNAL OF CLINICAL ONCOLOGY

Independent Adjudication of Symptomatic Heart Failure With the Use of Doxorubicin and Cyclophosphamide Followed by Trastuzumab Adjuvant Therapy: A Combined Review of Cardiac Data From the National Surgical Adjuvant Breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 Clinical Trials

(2010) Stuart D. Russell et al.   JOURNAL OF CLINICAL ONCOLOGY

Troponin I Provides Insight Into Cardiotoxicity and the Anthracycline-Trastuzumab Interaction

(2010) Michael S. Ewer et al.   JOURNAL OF CLINICAL ONCOLOGY

Role of Three-Dimensional Echocardiography in Breast Cancer: Comparison With Two-Dimensional Echocardiography, Multiple-Gated Acquisition Scans, and Cardiac Magnetic Resonance Imaging

(2010) Jonathan Walker et al.   JOURNAL OF CLINICAL ONCOLOGY

Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation

(2010) Daniela Cardinale et al.   JOURNAL OF CLINICAL ONCOLOGY

Cardiotoxicity of anticancer treatments: what the cardiologist needs to know

(2010) Michael S. Ewer et al.   Nature Reviews Cardiology

Management of Trastuzumab-Related Cardiac Dysfunction

(2010) Joseph R. Carver   PROGRESS IN CARDIOVASCULAR DISEASES

Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab

(2009) James L. Hare et al.   AMERICAN HEART JOURNAL

Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring

(2009) A L Jones et al.   BRITISH JOURNAL OF CANCER

Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents

(2009) Gennaro Riccio et al.   FASEB JOURNAL

Cardiovascular Complications of Cancer Therapy

(2009) Edward T.H. Yeh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Utility of Tissue Doppler and Strain Rate Imaging in the Early Detection of Trastuzumab and Anthracycline Mediated Cardiomyopathy

(2009) Davinder S. Jassal et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Cardiac toxicity with anti-HER-2 therapies-what have we learned so far?

(2009) Evandro de Azambuja et al.   Targeted Oncology

Anthracycline-trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies

(2008) D. Rayson et al.   ANNALS OF ONCOLOGY

Metastatic breast cancer: The role of pegylated liposomal doxorubicin after conventional anthracyclines

(2008) Shailendra Verma et al.   CANCER TREATMENT REVIEWS

Cardiac Management During Adjuvant Trastuzumab Therapy: Recommendations of the Canadian Trastuzumab Working Group

(2008) John Mackey   Current Oncology

Anthracycline Cardiotoxicity: From Bench to Bedside

(2008) Luca Gianni et al.   JOURNAL OF CLINICAL ONCOLOGY

Left Ventricular Ejection Fraction and Cardiotoxicity: Is Our Ear Really to the Ground?

(2008) Michael S. Ewer et al.   JOURNAL OF CLINICAL ONCOLOGY